Role of Interleukin 5 Inhibition in the Treatment of Eosinophilic Otitis Media
Objective Eosinophilic otitis media (EOM) is a rare form of middle ear disease characterized by a viscous effusion rich in eosinophils, a resistance to conventional treatments, and an association with bronchial asthma. The relationship between asthma and EOM suggests similarities in pathogenesis and...
Main Authors: | Nathaniel K. Breslin, N. Hadley Heindel MD, Rex S. Haberman MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-02-01
|
Series: | OTO Open |
Online Access: | https://doi.org/10.1177/2473974X21991449 |
Similar Items
-
Role of IgE in Eosinophilic Otitis Media
by: Yukiko Iino
Published: (2010-01-01) -
A Case of Intractable Otitis Media: Eosinophilic Otitis Media
by: Mehmet Turgay Türkmen, et al.
Published: (2014-09-01) -
Cycling therapy with benralizumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media
by: Satoshi Hamada, et al.
Published: (2021-07-01) -
Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophilic otitis media
by: Hirotaka Uchimizu, et al.
Published: (2015-09-01) -
Interleukin-4 and interleukin-5 as targets for the inhibition of eosinophilic inflammation and allergic airways hyperreactivity
by: Paul S Foster, et al.
Published: (1997-12-01)